Literature DB >> 8660149

Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.

B Zappacosta1, D Monza, C Meoni, L Austoni, P Soliveri, C Gellera, R Alberti, M Mantero, G Penati, T Caraceni, F Girotti.   

Abstract

OBJECTIVES: To investigate the hypothesis that psychiatric disturbances in Huntington's disease are related to degree of cognitive or motor compromise and to determine correlations between CAG repeat length within the gene for Huntington's disease and disease severity.
DESIGN: Consecutive series of patients with Huntington's disease.
SETTING: Neurological specialty hospital. PATIENTS: Seventeen men and 12 women from 24 families. MAIN OUTCOME MEASURES: The Hamilton Psychiatric and Anxiety Rating Scales and Brief Psychiatric Rating Scale were used to assess psychiatric disturbances; Folstein's Quantified Neurological Examination to evaluate motor status; and the Mini-Mental State Examination, Raven Progressive Matrices), Phonemic Verbal Fluency Test, Short Tale Test, Visual Search Test, and Benton's Visual Orientation Line Test to evaluate cognitive function. The length of the CAG repeat sequence in the Huntington's gene was determined by quantitative polymerase chain reaction.
RESULTS: Cognitive test scores correlated significantly with each other; of these, results of the Visual Search and Short Tale tests correlated significantly with the Folstein's Quantified Neurological Examination score (P = .05 and P = .03, respectively). Results of the Folstein's Quantified Neurological Examination also correlated with the illness duration and the length of the CAG repeat. Although psychiatric scores correlated significantly among themselves (P < .01), neither cognitive compromise, motor deterioration, nor CAG length were related to the extent of psychiatric compromise. Patients who were depressed when they were examined tended to have a history of psychiatric disorders.
CONCLUSIONS: The lack of correlation between disease severity and psychiatric disturbances indicates that psychiatric disorders progress nonlinearly, possibly because of differential degeneration of the striatal-cortical circuits; the possibility that psychiatric disorders are prevalent in certain families with a member who has Huntington's disease is being further investigated. The lack of correlation between CAG length and cognitive and psychiatric variables needs further investigation.

Entities:  

Mesh:

Year:  1996        PMID: 8660149     DOI: 10.1001/archneur.1996.00550060035012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  16 in total

Review 1.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

Review 2.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

3.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.

Authors:  Eric A Epping; James A Mills; Leigh J Beglinger; Jess G Fiedorowicz; David Craufurd; Megan M Smith; Mark Groves; Kelly R Bijanki; Nancy Downing; Janet K Williams; Jeffrey D Long; Jane S Paulsen
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

4.  Conditional Gaussian graphical model for estimating personalized disease symptom networks.

Authors:  Shanghong Xie; Erin McDonnell; Yuanjia Wang
Journal:  Stat Med       Date:  2021-12-05       Impact factor: 2.373

Review 5.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

6.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

7.  Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.

Authors:  I Vuillaume; P Vermersch; A Destée; H Petit; B Sablonnière
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

8.  Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.

Authors:  Branduff McAllister; James F Gusella; G Bernhard Landwehrmeyer; Jong-Min Lee; Marcy E MacDonald; Michael Orth; Anne E Rosser; Nigel M Williams; Peter Holmans; Lesley Jones; Thomas H Massey
Journal:  Neurology       Date:  2021-03-25       Impact factor: 11.800

9.  Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.

Authors:  Megan M Smith; James A Mills; Eric A Epping; Holly J Westervelt; Jane S Paulsen
Journal:  Neuropsychology       Date:  2012-07-30       Impact factor: 3.295

10.  Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree.

Authors:  Bernardo Barahona Corrêa; Miguel Xavier; João Guimarães
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.